Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment

Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment

BackgroundDetecting multiple sclerosis (MS) relapses remains challenging due to symptom variability and confounding factors, such as flare-ups and infections. Methylprednisolone (MP) is used for severe relapses, decreasing the number of contrast-enhancing lesions on MRI. The influx constant (Ki) der...

Full description

Saved in:
Bibliographic Details
Main Authors: Stig P. Cramer, Nizar Hamrouni, Helle J. Simonsen, Mark B. Vestergaard, Aravinthan Varatharaj, Ian Galea, Ulrich Lindberg, Jette Lautrup Frederiksen, Henrik B. W. Larsson
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Neuroscience
Subjects:
MRI
DCE MRI
perfusion MRI
blood–brain barrier
multiple sclerosis: multiple sclerosis relapses
methylprednisolone
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2025.1546236/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2025.1546236/full

Similar Items